Cargando…

3D-quantitative structure–activity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase

Curcumin derivatives have been shown to inhibit replication of human influenza A viruses (IAVs). However, it is not clear whether curcumin and its derivatives can inhibit neuraminidase (NA) of influenza virus. In this study, a meaningful 3D quantitative structure–activity relationship model (compara...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Yanni, Yan, Yiwen, Liao, Shanghui, Li, Yun, Ye, Yi, Liu, Ni, Zhao, Fang, Xu, Peiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pharmaceutical Society of Korea 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125423/ https://www.ncbi.nlm.nih.gov/pubmed/32248350 http://dx.doi.org/10.1007/s12272-020-01230-5

Ejemplares similares

Antiviral Activity of Isoimperatorin Against Influenza A Virus in vitro and its Inhibition of Neuraminidase
por: Lai, Yanni, et al.
Publicado: (2021)

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
por: Leang, Sook-Kwan, et al.
Publicado: (2017)

Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases
por: Hashem, Anwar M., et al.
Publicado: (2009)

Novel antiviral activity of neuraminidase inhibitors against an avian influenza a virus
por: Ushirogawa, Hiroshi, et al.
Publicado: (2011)

A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
por: Byrne-Nash, Rose T., et al.
Publicado: (2019)

Correction: Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases
por: Hashem, Anwar M., et al.
Publicado: (2013)

Structure-based design of 5′-substituted 1,2,3-triazolylated oseltamivir derivatives as potent influenza neuraminidase inhibitors
por: Wang, Pengfei, et al.
Publicado: (2021)

Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan
por: Chong, Yong, et al.
Publicado: (2019)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016–2017
por: Lackenby, Angie, et al.
Publicado: (2018)

Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011)

Systematic review of influenza resistance to the neuraminidase inhibitors
por: Thorlund, Kristian, et al.
Publicado: (2011)

The role of neuraminidase inhibitors in the treatment and prevention of influenza
por: Naem, Shahrour
Publicado: (2001)

Exploring the chemical space of influenza neuraminidase inhibitors
por: Anuwongcharoen, Nuttapat, et al.
Publicado: (2016)

Exploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitors
por: Liao, Laura E., et al.
Publicado: (2017)

Bacterial Neuraminidase Rescues Influenza Virus Replication from Inhibition by a Neuraminidase Inhibitor
por: Nishikawa, Tomoko, et al.
Publicado: (2012)

Economics of Neuraminidase Inhibitor Stockpiling for Pandemic Influenza, Singapore
por: Lee, Vernon J., et al.
Publicado: (2006)

Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
por: Kamali, Amanda, et al.
Publicado: (2013)

Targeted vs. systematic early antiviral treatment against A(H1N1)v influenza with neuraminidase inhibitors in patients with influenza-like symptoms: Clinical and economic impact
por: Deuffic-Burban, Sylvie, et al.
Publicado: (2009)

Synergistic Antiviral Activity of S-033188/S-033447, a Novel Inhibitor of Influenza Virus Cap-Dependent Endonuclease, in Combination with Neuraminidase Inhibitors In Vitro
por: Kitano, Mitsutaka, et al.
Publicado: (2017)

Plasticity of the 340-Loop in Influenza Neuraminidase Offers New Insight for Antiviral Drug Development
por: Han, Nanyu, et al.
Publicado: (2020)

Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies
por: Job, E. R., et al.
Publicado: (2019)

A novel N-heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation
por: Zhang, Jiwei, et al.
Publicado: (2023)

Antiviral Activity of Benzoic Acid Derivative NC-5 Against Influenza A Virus and Its Neuraminidase Inhibition
por: Guo, Min, et al.
Publicado: (2019)

Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: influence of neuraminidase inhibitors
por: Delgado-Rodríguez, Miguel, et al.
Publicado: (2012)

Generation and Characterization of Recombinant Influenza A(H1N1) Viruses Resistant to Neuraminidase Inhibitors
por: Choi, WooYoung, et al.
Publicado: (2013)

In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2015)

Effects of Vaccination and the New Neuraminidase Inhibitor, Laninamivir, on Influenza Infection
por: Mizuno, Takuro, et al.
Publicado: (2014)

Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada
por: Abed, Yacine, et al.
Publicado: (2019)

Influenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological Activity
por: Laborda, Pedro, et al.
Publicado: (2016)

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
por: Jefferson, Tom, et al.
Publicado: (2014)

Synthesis of Sulfo-Sialic Acid Analogues: Potent Neuraminidase Inhibitors in Regards to Anomeric Functionality
por: Vavricka, Christopher J., et al.
Publicado: (2017)

Ensemble-Based Virtual Screening Reveals Potential Novel Antiviral Compounds for Avian Influenza Neuraminidase
por: Cheng, Lily S., et al.
Publicado: (2008)

Antiviral Effect of Isoquercitrin against Influenza A Viral Infection via Modulating Hemagglutinin and Neuraminidase
por: Cho, Won-Kyung, et al.
Publicado: (2022)

Quantitative Predictions of Binding Free Energy Changes in Drug-Resistant Influenza Neuraminidase
por: Ripoll, Daniel R., et al.
Publicado: (2012)

In Vitro and In Vivo Antiviral Studies of New Heteroannulated 1,2,3-Triazole Glycosides Targeting the Neuraminidase of Influenza A Viruses
por: Kutkat, Omnia, et al.
Publicado: (2022)

Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010–2015
por: Tewawong, Nipaporn, et al.
Publicado: (2018)

Neuraminidase inhibitors sensitivity in Cambodian H5N1 and H1N1 pandemic influenza viruses
por: Naughtin, M, et al.
Publicado: (2011)

Fc-Effector-Independent in vivo Activity of a Potent Influenza B Neuraminidase Broadly Neutralizing Antibody
por: Khalil, Ahmed M., et al.
Publicado: (2023)

Neuraminidase Inhibitor Resistance in Influenza: Assessing the Danger of Its Generation and Spread
por: Handel, Andreas, et al.
Publicado: (2007)

Effectiveness of Neuraminidase Inhibitors for Preventing Staff Absenteeism during Pandemic Influenza
por: Lee, Vernon J., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_4bbc5s91eb2nvjp025a9al1agd